BRIEF-EMA Publishes Assessment Report For Spikevax Supporting Its Extension Of Indication For Use In Children Aged 6 Months-5 Yrs

BRIEF-EMA Publishes Assessment Report For Spikevax Supporting Its Extension Of Indication For Use In Children Aged 6 Months-5 Yrs

EMA:

* EMA: EMA PUBLISHED THE ASSESSMENT REPORT FOR SPIKEVAX SUPPORTING ITS EXTENSION OF INDICATION FOR USE IN CHILDREN AGED 6 MONTHS TO 5 YEARS

Give Feedback

Use this form for editorial or site feedback. We usually reply within 2 to 3 working days.

By submitting, you agree that we may use your email address to respond.